K132892

Substantially Equivalent

TEBCO-W

Applicant: Bomed, Inc.
Product code: DXG
Advisory panel: Cardiovascular
Date received: 2013-09-16
Decision date: 2014-08-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Kamuela, HI, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.